about
sameAs
Improving the extent of malignant glioma resection by dual intraoperative visualization approachHidden association of Cowden syndrome, PTEN mutation and meningioma frequencyTemozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosisEpigenetics in Brain Tumors: HDACs Take Center StageDexamethasone alleviates tumor-associated brain damage and angiogenesisA new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sproutingSynaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling.Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas.Perforant path lesion induces up-regulation of stathmin messenger RNA, but not SCG10 messenger RNA, in the adult rat hippocampus.Regulation of expression of the phospholipid hydroperoxide/sperm nucleus glutathione peroxidase gene. Tissue-specific expression pattern and identification of functional cis- and trans-regulatory elements.Surgical resection of malignant gliomas-role in optimizing patient outcome.Molecules involved in reactive sprouting in the hippocampus.Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function.The impact of dietary isoflavonoids on malignant brain tumorsMolecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element.A new functional classification system (FGA/B) with prognostic value for glioma patients.Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potentialSupra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastomaPlasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injury.xCT modulation in gliomas: relevance to energy metabolism and tumor microenvironment normalization.Brain miffed by macrophage migration inhibitory factor.Selenium action in neuro-oncology.Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis toolNrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosisATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma.Ferroptosis and Cell Death Analysis by Flow Cytometry.A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brainSunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.Rac controls PIP5K localisation and PtdIns(4,5)P₂ synthesis, which modulates vinculin localisation and neurite dynamics.Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis.MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema.Biochemical analysis of selenoprotein expression in brain cell lines and in distinct brain regions.The role of selenite on microglial migration.Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo.Neurodegeneration and the Brain Tumor Microenvironment. [corrected]Identification of neuronal cell death in a model of degeneration in the hippocampus.PRG3 induces Ras-dependent oncogenic cooperation in gliomas.
P50
Q21090866-6492CADF-93E6-4E03-A5EE-25309387712EQ26739125-8A146C8D-DD29-4988-B6B8-766513B9370CQ28066155-4E15B43F-8FB2-4B1D-8644-BB4143C8264DQ28080964-AA4F4732-7FD1-4001-ABE0-28D581F44C0FQ28542092-CA504B39-4609-40A8-B3A7-F851A64AE093Q28570574-B269EA79-C504-41E4-B1B5-83861F4D984CQ30541600-5580EA03-CF0E-4A63-9B8B-DC6133EB4EEEQ30617352-376BFCBF-A522-4493-9B0F-72797A1F14CDQ32065661-89050B15-B2F7-4814-AB38-B75A92C87378Q34158609-1CB78620-24FE-4BB5-B6CD-B557CF8055E5Q34324963-FB4EE9B9-523E-45AC-862F-4BFF2B484491Q34371677-A933B6A8-C3E3-4BC1-9126-1C6F890501FDQ34655209-45F22977-613B-47B2-8CE2-5EA8CA274EDCQ35000427-C654729B-C9F2-44A9-A1DD-7D9689B92A19Q35716547-C68B2A31-F38E-4EE3-8AC2-22CAC590C409Q36288720-7D3F6895-5E4C-400D-8C70-33800E3EDC71Q36528067-D4A74978-EA6E-4BF3-BB6C-5BF7D2B5C10FQ37295485-1A85079A-D863-4023-93A8-580A717D9544Q37423545-50585C66-B89B-43C3-BA03-66575A7036A8Q37783819-BCD075B8-A16E-4166-9B11-FCAFE4EE94C6Q38042932-ED48C1B0-1978-4DE1-81BA-42A0C0E35E0DQ38243994-52EBDCD4-AD77-4C78-9E1D-CAD8A0FA270DQ38611037-B60D4186-3643-42EE-BFBA-AD8D12F23978Q38626095-01D9321C-3B50-44F3-93F9-CB85A9AB8600Q38758632-91A51239-A930-4317-B52F-4CCA82714A37Q38786321-AEB9A39E-E429-493B-A8E0-C6E85463FAF3Q38805671-1D774F68-83FB-4F9A-B506-3386FACA6041Q38811448-9F05FC85-EB1B-4026-BFBF-0A39A9FFA8E1Q38933860-B5B761B0-5BC8-4907-B953-F2086C3D30DFQ39655961-963138EA-268F-47D5-86B7-ED325C6F206FQ39662069-904D1976-57F5-40FC-9516-9FC4323150E5Q39749702-E552FB2C-2252-4F2E-93E5-3538DE8804C9Q39784779-14349D2E-ECD5-46BD-A861-EAA153A0B33AQ39983715-3B47CB36-E48A-4F03-A51E-B16FDE6D0B78Q40006063-E8921270-1634-4EB1-A252-41DA85054783Q40150232-D4FC45A1-3170-4314-B153-B93D1E8F6161Q40430014-4DB1F81B-A0DB-4DA9-B812-3DADD35CC18EQ40494622-F1776717-E628-4DC5-99BB-C39B1D481F89Q40655278-A023F89C-C150-4CBF-8F52-96ECEB10A96DQ41225581-07B07874-D7F2-41F2-8D64-03DC2A755856
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nic E Savaskan
@nl
Nic E Savaskan
@sl
Nic E. Savaskan
@en
Nic E. Savaskan
@es
type
label
Nic E Savaskan
@nl
Nic E Savaskan
@sl
Nic E. Savaskan
@en
Nic E. Savaskan
@es
altLabel
Nic Savaskan
@en
Nicolai E. Savaskan
@en
prefLabel
Nic E Savaskan
@nl
Nic E Savaskan
@sl
Nic E. Savaskan
@en
Nic E. Savaskan
@es
P1053
D-2923-2018
P106
P1153
6603818140
P21
P31
P3829
P496
0000-0003-1348-094X